Xeris Pharmaceuticals | XERS - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Celltrion KRW 19B 1.96B 2025-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 0 2026-06
Eli Lilly USD 114.7M 134.3M 2025-09
Kangmei Pharma CNY 1.82M 150K 2025-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Medical Developments International AUD 18K 3K 2025-06
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Neuren Pharmaceuticals AUD 0 0 2024-06
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pacira USD 3.62M 77K 2026-06
Perrigo USD 7.61B 373.8M 2026-06
Pharma Mar EUR 117K 1.24M 2025-09
Qiagen NV USD 10.02M 1.03M 2026-06
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Supernus Pharmaceuticals USD 910K 278K 2023-06
Tilray USD 6.7M 2.73M 2025-06
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06